Indeed, when administered as monotherapy or in combination with a SERT inhibitor, nisoxetine reversed Parkinsonism in the MPTP-lesioned marmoset, suggesting that both selective NET and mixed NET = SERT inhibitors might represent effective anti-Parkinsonian therapies when administered as monotherapy. The gene discussed is SLC6A4; the disease is Parkinson disease.